Novel Insights in Clinical Diagnosis and Therapies of Heart Failure
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 October 2020) | Viewed by 3674
Special Issue Editor
Interests: sports and fitness nutrition; nutrition and metabolic syndrome; diet and cardiovascular diseases; aging and pharmacological responses; fluid electrolyte balance and homeostasis; genetic biomarkers of inflammation and oxidative stress; microbiome; food intolerance testing
Special Issue Information
Dear Colleagues,
Cardiovascular disease is currently amongst the most common causes of morbidity and mortality in developed countries. Cardiovascular disease is a broad term that includes hypertension, coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure, rheumatic heart disease, congenital heart disease, and cardiomyopathies. Heart failure is thus a highly prevalent condition with a devastating impact on patients’ lives and with increasing heath care costs. To date, there is no single diagnostic test for heart failure. It requires a history, physical examination, and laboratory testing. Therefore, achievements in appropriate diagnosis would be highly important. In order to treat cardiovascular diseases, scientists have focused their efforts on looking at the factors contributing to its etiopathogenesis and also on trying to develop brand new treatments. New insights are also a goal towards the discovery of brand new treatment and novel drugs with fewer underlying untoward effects as well as a rapid progress in gene therapy, which may be one of the options for the treatment of cardiovascular diseases. The aim of this Special Issue is to stimulate interest in developing discoveries and trends for either an early diagnosis or a more effective treatment for heart failure.
Dr. Pierluigi Pompei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular diseases
- heart failure
- antihypertensive drugs
- metabolic syndrome
- aging
- cardiomyopathies
- kidney disease
